IL1B and COVID-19: We have previously shown the neuroprotective potential of naringenin through modulation of inflammatory mediators (NF-κB, TNF-α, IL-1β, etc) and microglia activation in the CNS (Nouri et al., 2019), thereby it could mitigate the neuronal signs of COVID-19 mediated by the inflammatory mediators.